Literature DB >> 15911120

Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures.

Rafal M Kaminski1, Toni S Shippenberg, Jeffrey M Witkin, Beatriz A Rocha.   

Abstract

Norepinephrine (NE) has been reported to modulate neuronal excitability and act as endogenous anticonvulsant. In the present study we used NE transporter knock-out mice (NET-KO), which are characterized by high levels of extracellular NE, to investigate the role of endogenous NE in seizure susceptibility. Seizure thresholds for cocaine (i.p.), pentylenetetrazol (i.v.) and kainic acid (i.v.) were compared in NET-KO, heterozygous (NET-HT) and wild type (NET-WT) female mice. The dose-response curve for cocaine-induced convulsions was significantly shifted to the right in NET-KO mice, indicating higher seizure thresholds. The threshold doses of pentylenetetrazol that induced clonic and tonic seizures were also significantly higher in NET-KO when compared to NET-WT mice. Similarly, NET-KO mice displayed higher resistance to convulsions engendered by kainic acid. For all drugs tested, the response of NET-HT mice was always intermediate. These data provide further support for a role of endogenous NE in the control of seizure susceptibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911120      PMCID: PMC1352306          DOI: 10.1016/j.neulet.2005.02.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Anticonvulsant effects of clonidine mediated through central alpha2-adrenoceptors.

Authors:  J Papanicolaou; R J Summers; F J Vajda; W J Louis
Journal:  Eur J Pharmacol       Date:  1982-01-22       Impact factor: 4.432

2.  Systemic overexpression of the alpha 1B-adrenergic receptor in mice: an animal model of epilepsy.

Authors:  Takeharu Kunieda; Michael J Zuscik; Atthaporn Boongird; Dianne M Perez; Hans O Lüders; Imad M Najm
Journal:  Epilepsia       Date:  2002-11       Impact factor: 5.864

3.  Potentiated opioid analgesia in norepinephrine transporter knock-out mice.

Authors:  L M Bohn; F Xu; R R Gainetdinov; M G Caron
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

Review 4.  Use of anticonvulsants for treatment of neuropathic pain.

Authors:  Misha-Miroslav Backonja
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

5.  The relationship between alpha 2-adrenoceptor selectivity and anticonvulsant effect in a series of clonidine-like drugs.

Authors:  J Papanicolaou; R J Summers; F J Vajda; W J Louis
Journal:  Brain Res       Date:  1982-06-10       Impact factor: 3.252

Review 6.  The role of norepinephrine in epilepsy: from the bench to the bedside.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Francesca Biagioni; Luigi Murri; Francesco Fornai
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

Review 7.  The role of catecholamines in seizure susceptibility: new results using genetically engineered mice.

Authors:  David Weinshenker; Patricia Szot
Journal:  Pharmacol Ther       Date:  2002-06       Impact factor: 12.310

8.  Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures.

Authors:  H Baran; G Sperk; H Hörtnagl; G Sapetschnig; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1985-07-17       Impact factor: 4.432

9.  Dexmedetomidine increases the cocaine seizure threshold in rats.

Authors:  Robert A Whittington; Laszlo Virag; Yvonne Vulliemoz; Thomas B Cooper; Hisayo O Morishima
Journal:  Anesthesiology       Date:  2002-09       Impact factor: 7.892

10.  Pharmacological modulation of GABA(B) receptors affects cocaine-induced seizures in mice.

Authors:  Maciej Gasior; Rafal Kaminski; Jeffrey M Witkin
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

View more
  10 in total

1.  Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.

Authors:  Heinrich J G Matthies; Jessica L Moore; Christine Saunders; Dawn Signor Matthies; Lynne A Lapierre; James R Goldenring; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  The relevance of individual genetic background and its role in animal models of epilepsy.

Authors:  P Elyse Schauwecker
Journal:  Epilepsy Res       Date:  2011-10-15       Impact factor: 3.045

Review 3.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.

Authors:  Rafal M Kaminski; Zhanyan Fu; Kumar Venkatesan; Manuela Mazzuferi; Karine Leclercq; Vincent Seutin; Stefano Vicini
Journal:  Neuropharmacology       Date:  2010-09-29       Impact factor: 5.250

5.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.

Authors:  H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn
Journal:  Genes Brain Behav       Date:  2013-10-09       Impact factor: 3.449

Review 6.  Rhythm and blues: animal models of epilepsy and depression comorbidity.

Authors:  S Alisha Epps; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

7.  Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures.

Authors:  Meriem Gaval-Cruz; Jason P Schroeder; L Cameron Liles; Martin A Javors; David Weinshenker
Journal:  Pharmacol Biochem Behav       Date:  2008-02-12       Impact factor: 3.533

8.  Subcellular localization of the antidepressant-sensitive norepinephrine transporter.

Authors:  Heinrich J G Matthies; Qiao Han; Angela Shields; Jane Wright; Jessica L Moore; Danny G Winder; Aurelio Galli; Randy D Blakely
Journal:  BMC Neurosci       Date:  2009-06-23       Impact factor: 3.288

Review 9.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

10.  Novel actions of oxazolidinones: in vitro screening of a triazolyloxazolidinone for anticonvulsant activity.

Authors:  Samuel B Kombian; Oludotun A Phillips
Journal:  Med Princ Pract       Date:  2012-12-21       Impact factor: 1.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.